Dieter Bielang

Dieter Bielang brings over 35 years of experience in the medical device industry, with over 20 years spent working in early-stage companies. Throughout his career, Mr. Bielang has held sales management and marketing positions in various therapeutic areas such as urology (CR Bard), anesthesia (Rusch-Teleflex), gynecology (Influence), orthopedics (Disc-O-Tech), neuroradiology (EndoVasix), and over the last 15 years in phlebology/vascular (VNUS, Covidien, and Sapheon). At VNUS, Mr. Bielang was responsible for launching and establishing a dominant market position for the VNUS RF Closure System in Europe and other markets outside the United States. After VNUS was acquired by Covidien in 2009, Mr. Bielang held the position as Vice President Sales & Marketing, Vascular Interventions at Covidien Europe and was responsible for the integration of the newly developed Covidien vascular team. With his efforts, Covidien became the market leader in the thermal ablation technique for varicose veins. In 2012, Mr. Bielang became International Sales Director Europe at Sapheon (later acquired by Covidien, now part of Medtronic). He was responsible for the market development and commercialization of the VenaSeal Closure System – a non-thermal ablation technology for venous reflux disease – in the European phlebology market. Mr. Bielang holds a Business College Diploma from the Commercial Education College Stuttgart/Waiblingen.